Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AzurRx Will Take First Wave Name After
IN VITRO DIAGNOSTICS Mergers & Acquisitions Grifols SA Progenika Biopharma SA Grifols SA (hemotherapy, diagnostics, and hospital IV drugs) is acquiring a 60% stake in privately held diagnostics co